SCHEMBL7599788

SCHEMBL7599788

Nc1ccc2cccc3c2c1C(=O)NC3=O.Nc1cccc2c1C(=O)NC2=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 3/20 0.58
▸ MEN1 O00255 3/20 0.53
▸ KMT2A Q03164 3/20 0.53
▸ NPSR1 Q6W5P4 2/20 0.53
▸ USP2 O75604 2/20 0.53
▸ POLB P06746 2/20 0.53
▸ MAPT P10636 2/20 0.53
▸ RGS12 O14924 1/20 0.53
▸ CYP1A2 P05177 1/20 0.53
▸ CYP3A4 P08684 1/20 0.53
▸ THRB P10828 1/20 0.53
▸ CYP2C9 P11712 1/20 0.53
▸ APEX1 P27695 1/20 0.53
▸ CASP1 P29466 1/20 0.53
▸ BRCA1 P38398 1/20 0.53
▸ MTOR P42345 1/20 0.53
▸ RECQL P46063 1/20 0.53
▸ BLM P54132 1/20 0.53
▸ CASP7 P55210 1/20 0.53
▸ GNAI1 P63096 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL339347 0.95 PARP1 (0.63) PARP1MEN1KMT2ANPSR1USP2
SCHEMBL221618 0.85 PARP1 (0.53) PARP1MEN1KMT2ANPSR1USP2
SCHEMBL29372946 0.85 PARP1 (0.53) PARP1MEN1KMT2ANPSR1USP2
SCHEMBL4113021 0.83 PARP1 (0.56) PARP1MEN1KMT2ANPSR1USP2
SCHEMBL28012033 0.83 PARP1 (0.52) PARP1MEN1KMT2ANPSR1USP2
SCHEMBL21450709 0.79 PARP1 (0.63) PARP1MEN1KMT2ANPSR1USP2
SCHEMBL28244498 0.77 PARP1 (0.95) PARP1MEN1KMT2ANPSR1USP2
SCHEMBL29089233 0.77 PARP1 (0.66) PARP1MEN1KMT2ANPSR1USP2
SCHEMBL7936537 0.77 RAD52 (0.44) PARP1MEN1KMT2ANPSR1USP2
SCHEMBL6848270 0.76 PARP1 (0.63) PARP1MEN1KMT2ANPSR1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020025940-A1 Methods and compositions for sensitive and rapid, functional identification of genomic polynucleotides and use for cellular assays in drug discovery AURORA BIOSCIENCES CORPORATION 2002-02-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020025940-A1 Methods and compositions for sensitive and rapid, functional identification of genomic polynucleotides and use for cellular assays in drug discovery PHAX, POLRMT, POLI PARP1 662/4885MEN1 3890/4885KMT2A 4043/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback